16.35-18.10 ADVANCING IN TECHNOLOGY AND APPLICATIONS: SESSION I

16:35 – 16:50 Nucleosomas como nueva prueba basada en sangre para caracterizar tumores
Nucleosomes as new blood based test to characterize tumours

Mr. Mark Eccleston, Business Development Director at Volition. Inses, Belgium

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/1.-Dr.-Mark-Eccleston.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]


16:50 – 17:05 Perfiles genómicos utilizados en biopsia líquida
Genomic profi les employed in liquid biopsy

Dr. Emiliano Calvo, START Madrid CIOCC, Centro Integral Oncológico Clara Campal. Madrid

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/2.-Dr.-Emiliano-Calvo.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]


17:05 – 17:20 Sistemas de microfluídica para aislamiento de CTCs
Microfl uidic technologies for CTCs isolation
Dra. Lorena Diéguez, International Iberian Nanotechnology Laboratory – INL. Braga, Portugal

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/02/Dra.LorenaDieguez.pdf” target=”blank” background=”#41b9e3″]Presentación[/su_button]


17:20 – 17:35 ERASE-SEQ: Detección precisa de variantes somáticas de baja frecuencia en cfDNA
ERASE-Seq: accurate detection of low frequency domatic variants in cfDNA

Mr. Cristian Ionescu, Chief Technology Offi cer at Fluxion Biosciences. Alameda, California, USA

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/4.-Dr.-Cristian-Ionescu-Zanetti.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

18.10-18.20 Public procurement of innovation applied to oncology: Código 100 innovation plan

Dr. Luis León, Axencia de Coñecemento en Saúde-ACIS. Santiago de Compostela

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/Dr.-Luis-Leon.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

18.40-20.00 ADVANCING IN TECHNOLOGY AND APPLICATIONS: SESSION II

18:55 – 19:10 La experiencia de la biopsia líquida de OncoBEAM en la práctica clínica del mundo real
The OncoBEAM liquid biopsy experience in real-world clinical practice
Mr. Frederick S. Jones, Director Medical Affairs Liaison at Sysmex-Inostics. Mundelein, Illinois, USA

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/2.-Dr.-Frederick-S.-Jones.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]


19:10 – 19:25 Enriquecimiento CTC con PARSORTIX™: clinical applicationsCTC
Enrichment with PARSORTIX™: clinical applications
Dra. Eva Obermayr, Medical University Vienna. Austria

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/3.-Dra.-Eva-Obermayr.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

Passatge Batlló, 15
Barcelona

T. +34 93 451 17 24
F. 93 451 43 66

info@tacticsmd.net
www.tacticsmd.net


San Francisco Hotel Monumento
Campillo de San Francisco, 3
Santiago de Compostela
www.sanfranciscohm.com